Transcatheter Repair versus Mitral-Valve Surgery for Secondary Mitral Regurgitation

Among patients with heart failure and secondary mitral regurgitation, transcatheter edge-to-edge repair was noninferior to mitral-valve surgery with respect to a composite of death, rehospitalization for heart failure, stroke, reintervention, or implantation of an assist device in the left ventricle at 1 year. (Funded by Abbott Vascular; MATTERHORN ClinicalTrials.gov number, NCT02371512.).

Authors

Institutions

Publication Details

Journal
New England Journal of Medicine
Published
2024-08-31
DOI
https://doi.org/10.1056/nejmoa2408739
Citations
129
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
51.86
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Transcatheter Repair versus Mitral-Valve Surgery for Secondary Mitral Regurgitation

Christian M. Hagl, Malte Kelm, Volker Rudolph, Hüseyin İnce et al.
129 citations
New England Journal of Medicine
Cardiac Valve Diseases and Treatments
51.86
article

Transcatheter Repair versus Mitral-Valve Surgery for Secondary Mitral Regurgitation

Christian M. Hagl, Malte Kelm, Volker Rudolph, Hüseyin İnce, Jan Fritz Gummert, Torsten Doenst, Jörg Schröder, Roman Pfister, Ulrich Fischer‐Rasokat, Thomas Walther, Martin Hellmich, Peter Boekstegers, Sebastian Reith, Mirjam Keßler, Jörg Hausleiter, Stephan Baldus, Wolfgang Rottbauer, Ralph Stephan von Bardeleben, Ingo Eitel, Julia Frank, Philipp Lurz, Hermann Reichenspurner, Thorsten Wahlers, Harald Beucher, Alexander Schmeißer, Thilo Noack, Edith Lubos, P. Christian Schulze, W.‐U. Müller, Alexander Bufe, Holger Thiele
article en
129 citations

Abstract

Among patients with heart failure and secondary mitral regurgitation, transcatheter edge-to-edge repair was noninferior to mitral-valve surgery with respect to a composite of death, rehospitalization for heart failure, stroke, reintervention, or implantation of an assist device in the left ventricle at 1 year. (Funded by Abbott Vascular; MATTERHORN ClinicalTrials.gov number, NCT02371512.).

New England Journal of MedicineVol. 391(19)
Friedrich Schiller University Jena (DE)
Openalex Percentile: Top 0%
Cardiac Valve Diseases and Treatments
51.86
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.